{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20200612",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 3",
          "submission_class_code_description": "Type 3 - New Dosage Form",
          "application_docs": [
            {
              "id": "63566",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213983s000lbl.pdf",
              "date": "20200615",
              "type": "Label"
            },
            {
              "id": "63574",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/213983Orig1s000ltr.pdf",
              "date": "20200616",
              "type": "Letter"
            },
            {
              "id": "65174",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/213983Orig1s000TOC.html",
              "date": "20201109",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "6",
          "submission_status": "AP",
          "submission_status_date": "20251028",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "83983",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/204790Orig1s033;213983Orig1s006ltr.pdf",
              "date": "20251029",
              "type": "Letter"
            },
            {
              "id": "83991",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/213983s006lbl.pdf",
              "date": "20251029",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20240418",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "78162",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204790s031,213983s004lbl.pdf",
              "date": "20240419",
              "type": "Label"
            },
            {
              "id": "78171",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/204790Orig1s031; 213983Orig1s004ltr.pdf",
              "date": "20240419",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20210709",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "68051",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204790s028,213983s002lbl.pdf",
              "date": "20210712",
              "type": "Label"
            },
            {
              "id": "68063",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/204790Orig1s028; 213983Orig1s002ltr.pdf",
              "date": "20210713",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20221007",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "72286",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/204790Orig1s030,213983Orig1s003ltr.pdf",
              "date": "20221011",
              "type": "Letter"
            },
            {
              "id": "72299",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204790s030,213983s003lbl.pdf",
              "date": "20221011",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20210323",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "66856",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/204790Orig1s029,213983Orig1s001ltr.pdf",
              "date": "20210324",
              "type": "Letter"
            },
            {
              "id": "66864",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204790s029,213983s001lbl.pdf",
              "date": "20210325",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "NDA213983",
      "sponsor_name": "VIIV HLTHCARE",
      "openfda": {
        "application_number": [
          "NDA213983"
        ],
        "brand_name": [
          "TIVICAY PD"
        ],
        "generic_name": [
          "DOLUTEGRAVIR SODIUM"
        ],
        "manufacturer_name": [
          "ViiV Healthcare Company"
        ],
        "product_ndc": [
          "49702-255",
          "49702-226",
          "49702-227",
          "49702-228"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "DOLUTEGRAVIR SODIUM"
        ],
        "rxcui": [
          "1433873",
          "1433879",
          "1796077",
          "1796079",
          "1796081",
          "1796083",
          "2374562",
          "2374566"
        ],
        "spl_id": [
          "a9175b83-2200-4bd2-9ee3-52095b5d2657"
        ],
        "spl_set_id": [
          "63df5af3-b8ac-4e76-9830-2dbb340af922"
        ],
        "package_ndc": [
          "49702-255-37",
          "49702-226-13",
          "49702-227-13",
          "49702-228-13"
        ],
        "unii": [
          "1Q1V9V5WYQ"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "TIVICAY PD",
          "active_ingredients": [
            {
              "name": "DOLUTEGRAVIR SODIUM",
              "strength": "EQ 5MG BASE"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "TABLET, FOR SUSPENSION",
          "route": "ORAL",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}